The non-natural cyclic amino acids
(1S,3R,4S)-1-amino-3-fluoro-4-(fluoro-18
F)cyclopentane-1-carboxylic acid ([18F]9) and (1S,3S,4R)-1-amino-3-fluoro-4-(fluoro-18
F)cyclopentane-1-carboxylic acid ([18F]28)
have been prepared in 10 and 1.7% decay corrected radiochemical yield,
respectively, and in greater than 99% radiochemical purity. Cell assays
in rat 9L gliosarcoma, human U87 ΔEGFR glioblastoma, and human
DU145 androgen-independent prostate carcinoma tumor cells indicated
that both compounds are substrates for amino acid transport primarily
by system L, with some transport taking place via system ASC. In rats
with 9L gliosarcoma, [18F]9 and [18F]28 provided high tumor to normal brain tissue ratios,
with maximal ratios of 3.5 and 4.1, respectively. Biodistribution
studies in healthy rats confirmed that both compounds are BBB permeable
and that bladder accumulation is low until at least 5 min post injection.